Package 45963-305-09

Brand: dextroamphetamine sulfate

Generic: dextroamphetamine sulfate
NDC Package

Package Facts

Identity

Package NDC 45963-305-09
Digits Only 4596330509
Product NDC 45963-305
Description

90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (45963-305-09)

Marketing

Marketing Status
Marketed Since 2014-06-19
Brand dextroamphetamine sulfate
Generic dextroamphetamine sulfate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "352be1be-4f30-4afe-9ec2-6108c1b9a9d7", "openfda": {"unii": ["JJ768O327N"], "rxcui": ["884520", "884532", "884535"], "spl_set_id": ["9e92ccc3-d81c-461d-a19f-7e9b582be357"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (45963-305-09)", "package_ndc": "45963-305-09", "marketing_start_date": "20140619"}], "brand_name": "dextroamphetamine sulfate", "product_id": "45963-305_352be1be-4f30-4afe-9ec2-6108c1b9a9d7", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "45963-305", "dea_schedule": "CII", "generic_name": "dextroamphetamine sulfate", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "dextroamphetamine sulfate", "active_ingredients": [{"name": "DEXTROAMPHETAMINE SULFATE", "strength": "15 mg/1"}], "application_number": "ANDA203901", "marketing_category": "ANDA", "marketing_start_date": "20140619", "listing_expiration_date": "20261231"}